Resveratrol ameliorates experimental autoimmune myocarditis

被引：66
作者：
Yoshida, Yuki [1 ]
Shioi, Tetsuo [1 ]
Izumi, Tohru [1 ]
机构：
[1] Kitasato Univ, Sch Med, Dept Internal Med & Cardiol, Sagamihara, Kanagawa 228, Japan
来源：
CIRCULATION JOURNAL | 2007年 / 71卷 / 03期
关键词：
aging; heart failure; myocarditis; resveratrol;
D O I：
10.1253/circj.71.397
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background Myosin-induced autoimmune myocarditis of rats is a model of human dilated cardiomyopathy. Resveratrol is a natural polyphenol found in grapes and wine that is reported to have cardioprotective and immunomodulatory effects. Methods and Results To examine the effect of resveratrol on myocarditis, vehicle or resveratrol (50mg/kg per day) was administered to cardiac myosin immunized rats I day before the immunization. At 14 days after immunization, resveratrol had preserved cardiac function of myosin-immunized rats according to echocardiographic analysis. The heart weight/tibial length ratio of vehicle-treated myosin-immunized rats was increased by 1.8-fold compared with unimmunized rats, and resveratrol attenuated the heart weight increase. Resveratrol significantly decreased cellular infiltration, fibrosis, and expression of inflammatory cytokines in the myocardium. Expressions of antioxidant genes were increased in myosin-immunized hearts, and resveratrol decreased those expressions. Resveratrol also attenuated myocarditis 21 days after immunization. SIRT1, a potential effector of resveratrol, was increased in the myocardium of myosin-immunized rats compared with unimmunized rats. The SIRT1 protein was localized mainly in infiltrating mononuclear cells. Conclusions Resveratrol significantly ameliorated myocardial injury and preserved cardiac function in a rat model of autoimmune myocarditis. Resveratrol may be a therapeutic modality for myocarditis.
引用
收藏
页码：397 / 404
页数：8
相关论文
共 33 条
[1]   Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration [J].
Araki, T ;
Sasaki, Y ;
Milbrandt, J .
SCIENCE, 2004, 305 (5686) :1010-1013
[2]   The Sir2 family of protein deacetylases [J].
Blander, G ;
Guarente, L .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :417-435
[3]   Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase [J].
Brunet, A ;
Sweeney, LB ;
Sturgill, JF ;
Chua, KF ;
Greer, PL ;
Lin, YX ;
Tran, H ;
Ross, SE ;
Mostoslavsky, R ;
Cohen, HY ;
Hu, LS ;
Cheng, HL ;
Jedrychowski, MP ;
Gygi, SP ;
Sinclair, DA ;
Alt, FW ;
Greenberg, ME .
SCIENCE, 2004, 303 (5666) :2011-2015
[4]   VALIDATION IN AWAKE RATS OF A TAIL-CUFF METHOD FOR MEASURING SYSTOLIC PRESSURE [J].
BUNAG, RD .
JOURNAL OF APPLIED PHYSIOLOGY, 1973, 34 (02) :279-282
[5]   Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy [J].
Cheng, TH ;
Liu, JC ;
Lin, H ;
Shih, NL ;
Chen, YL ;
Huang, MT ;
Chan, P ;
Cheng, CF ;
Chen, JJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (02) :239-244
[6]   Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress [J].
Chua, KF ;
Mostoslavsky, R ;
Lombard, DB ;
Pang, WW ;
Saito, S ;
Franco, S ;
Kaushal, D ;
Cheng, HL ;
Fischer, MR ;
Stokes, N ;
Murphy, MM ;
Appella, E ;
Alt, FW .
CELL METABOLISM, 2005, 2 (01) :67-76
[7]   Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia [J].
Dernek, S ;
Ikizler, M ;
Erkasap, N ;
Ergun, B ;
Koken, T ;
Yilmaz, K ;
Sevin, B ;
Kaygisiz, Z ;
Kural, T .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2004, 38 (04) :245-254
[8]   SUDDEN UNEXPECTED DEATH IN PERSONS LESS-THAN-40 YEARS OF AGE [J].
DRORY, Y ;
TURETZ, Y ;
HISS, Y ;
LEV, B ;
FISMAN, EZ ;
PINES, A ;
KRAMER, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (13) :1388-1392
[9]  
Feng YH, 2002, ACTA PHARMACOL SIN, V23, P893
[10]   Immunomodulatory activity of resveratrol:: discrepant in vitro and in vivo immunological effects [J].
Gao, XH ;
Deeb, D ;
Media, J ;
Divine, G ;
Jiang, H ;
Chapman, RA ;
Gautam, SC .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (12) :2427-2435
1234